Recordati SpA (LTS:0KBS)
€ 51.75 -0.1 (-0.19%) Market Cap: 10.55 Bil Enterprise Value: 12.03 Bil PE Ratio: 28.29 PB Ratio: 5.99 GF Score: 92/100

Half Year 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Call Transcript

Jul 28, 2023 / 02:00PM GMT
Release Date Price: €46.78 (+1.73%)
Operator

Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Recordati conference call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Federica De Medici, Investor Relations and Corporate Communications. Please go ahead, madam.

Federica De Medici
Recordati Industria Chimica e Farmaceutica S.p.A. - Director of IR & Corporate Communications

Yes. Hello, everyone, and thank you for attending the Recordati conference call today. I'm pleased to be here with our CEO, Rob Koremans; and our CFO, Luigi Felice Corte, who will present the 2023 first half results. Then we'll be running you through the presentation. As usual, the set of slide is available on our website in the Investors section.

We are also joined today by our 2 heads of business units, Alberto Martinez for specialty and primary care and Scott Pescatore for rare disease. Both gentlemen will be on hand to answer your questions together with Rob and Luigi during the Q&A session.

I will now give the floor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot